Search

everythinglearnresearchcommunity

for

Search:↓

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

PRP therapy may effectively treat hair loss, but more research needed.

Dermatologists are more comfortable and proactive in treating male pattern hair loss than primary care physicians.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

Microneedling may help hair loss, but needs more research.

Topical finasteride is an effective and safer treatment for male hair loss.

The trial aims to test if spironolactone is an effective acne treatment for women without the side effects of current treatments.

Platelet-rich plasma is a safe and effective treatment for hair loss with high patient satisfaction.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Finasteride is a cost-effective option for treating BPH, reducing risk of urinary issues and surgery.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Laser hair removal effectiveness depends on targeting hair structures without harming the skin, and improvements require more research and expert collaboration.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.